ADVERTISING ON SOCIAL MEDIA: UPDATED GUIDELINE IN ITALY

On July 21st this year the Italian Ministry of Health (MoH) released a new guideline about the use of social…

READ

The Revolutionary Role of Artificial Intelligence in Medical Devices

Artificial Intelligence (AI) has been a true revolution in many sectors, but perhaps one of the most promising is that…

READ

MDR: EXTENSION OF TRANSITIONAL PERIOD FOR LEGACY MEDICAL DEVICES

With the publication in the Official Journal of the European Union, the amendment to Regulations (EU) 2017/745 and (EU) 2017/746…

READ

ENVIRONMENTAL LABELLING OF PACKAGING: REQUIREMENTS FOR COSMETIC PRODUCTS

In September 2020, Legislative Decree No. 116 of 3 September 2020 was published in the Italian Official Journal (IOJ), in…

READ

ALTERNATIVE APPROACH FOR CARCINOGENICITY TESTING OF PHARMACEUTICALS IMPLEMENTED AS ICH S1B(R1) ADDENDUM

The ICH S1B(R1) Guideline provides international regulatory guidance on approaches for evaluating the carcinogenic potential of small molecule pharmaceuticals. An…

READ

ELECTRONIC PRODUCT INFORMATION (ePI)

The European Medicines Agency (EMA) and its European medicines regulatory network partners are working to enable the use of electronic…

READ

BILINGUALISM REQUIREMENT FOR MEDICINES IN THE PROVINCE OF BOLZANO AND POSSIBLE EXEMPTIONS

The Italian Decree n. 219/2006 (implementing 2001/83/EC Directive and following amendments) establishes that at least the information reported in the…

READ

CRITERIA FOR MARKETING AUTHORIZATION (MA) NUMBER(S) ASSIGNMENT BY AIFA IN THE CONTEXT OF NEW MA/EXTENSION OR VARIATION APPLICATIONS

The Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA) has provided Marketing Authorization Holders (MAH) with the criteria used to…

READ

AIFA REPORT ON TIMELINES FOR PRICING AND REIMBURSEMENT PROCEDURES IN THE PERIOD 2018-2022

On 27 April 2023, the Italian Medicines Agency (AIFA) published a report on the timelines of “Pricing and Reimbursement” procedures…

READ

SWITZERLAND AND THE US SIGNED AN MRA RELATING TO PHARMACEUTICAL GOOD MANUFACTURING PRACTICE

Mutual Recognition Agreements (MRAs) are internationally binding agreements between countries that aim to facilitate market access and optimize the use…

READ